Advertisement

Studies Explore Anomalous Health Incidents Reported by Government Personnel

0

No differences seen in terms of clinical, research, biomarker assessments or in MRI modalities compared with controls

Atopic Dermatitis in Children Tied to Learning, Memory Difficulties

0

However, finding limited to children with neurodevelopmental comorbidities, like ADHD or learning disabilities

ADHD Meds Initiation Linked to Lower Rate of All-Cause Mortality

0

Significantly lower rates seen for all-cause mortality and unnatural-cause mortality, but not natural-cause mortality

AAN: Monoclonal Antibodies for MS During Breastfeeding Not Harmful

0

No association seen for mAb during breastfeeding with infant hospitalization, systemic antibiotic use, developmental delay

ALS Drug Relyvrio May Be Pulled From Market

0

Manufacturer may pull medication from the market following lackluster results from a large trial

Degenerative Cervical Myelopathy Patients Often Have Severe Residual Paresthesia

0

Residual paresthesia tied to significantly worse treatment satisfaction, even after accounting for quality of life

AAN: Three Pesticides Linked to Risk for Parkinson Disease

0

Highest versus lowest decile of application of simazine, lindane, atrazine linked to increased relative risks for Parkinson disease

Overall Stroke Rates Down, but Hemorrhagic Stroke Up in Recent Years

0

Overall stroke mortality decline slowed, with variations seen by age and region

Link Between Sleep Apnea, Incident Stroke Examined for Blacks, Whites

0

Among Whites, high OSA risk, provider-diagnosed sleep apnea, and PAP treatment linked to increased risk for incident stroke

FDA Delays Decision on New Alzheimer’s Drug

0
By Robin Foster HealthDay Reporter FRIDAY, March 8, 2024 (HealthDay News) -- Instead of approving the new Alzheimer's drug donanemab this month, as was expected,...